Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fmi2 Inhibitors

Fmi2 inhibitors are a class of chemical compounds designed to interfere with the function of the Fmi2 protein, which plays a role in various cellular processes. The Fmi2 protein, often a part of signaling pathways, can influence cellular communication, growth, and development. Inhibitors targeting Fmi2 often exhibit specific binding affinities that allow them to modulate the activity of the protein, impacting how it interacts with other cellular components. These inhibitors are typically designed to target the protein's active site or other key regulatory domains, preventing Fmi2 from performing its normal functions within the cell. The inhibition process usually involves competitive or allosteric binding mechanisms that disrupt the protein's conformational state or its ability to bind to other molecules.

The chemical structures of Fmi2 inhibitors are diverse, often featuring heterocyclic cores, which provide the necessary scaffold for binding interactions. Some inhibitors may contain functional groups that enhance solubility, stability, or bioavailability, ensuring that the compound remains active in biological environments. Structural variations are introduced to optimize their specificity and minimize off-target effects. The inhibitors may also possess properties like chirality, allowing for selective interaction with the Fmi2 protein. Advanced techniques such as structure-activity relationship (SAR) analysis are used to refine these molecules, enabling more efficient design. The development of Fmi2 inhibitors can be highly systematic, involving computational modeling, high-throughput screening, and iterative chemical modifications to enhance their inhibitory potency and selectivity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV-939 inhibits Wnt/β-catenin signaling, potentially impacting pathways associated with CELSR1.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

IWP-2 inhibits Wnt production, potentially modifying the PCP pathway and indirectly affecting CELSR1.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$214.00
$326.00
$1275.00
1
(0)

LGK-974 is a Wnt secretion inhibitor, which could indirectly influence CELSR1-related pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059, a MEK inhibitor, may have indirect effects on CELSR1 through MAPK/ERK pathway modulation.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine, a Hedgehog pathway inhibitor, might indirectly affect CELSR1, given the crosstalk between PCP and Hedgehog signaling.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT, a Notch pathway inhibitor, could influence pathways that intersect with CELSR1's role in cell polarity and development.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, could indirectly affect CELSR1 through PI3K/AKT pathway interactions with Wnt/PCP signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, might indirectly influence processes related to CELSR1 through mTOR pathway modulation.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542, an inhibitor of TGF-β receptors, might affect cellular processes where CELSR1 is involved due to TGF-β signaling interactions.

Vismodegib

879085-55-9sc-396759
sc-396759A
10 mg
25 mg
$82.00
$158.00
1
(0)

Vismodegib, a Hedgehog pathway inhibitor, could have indirect effects on CELSR1 activity through pathway crosstalk.